ExploreWatchlistsPricing
  1. JP-listed companies
  2. KANEKA CORPORATION
  3. Financials
  4. Repayments of term debt

KANEKA CORPORATION (4118)

Market cap
¥361.5B
P/E ratio
11x
Kaneka develops advanced materials, medical devices, solar technology, and nutrition products across four business units serving infrastructure, housing, healthcare, and food industries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRepayments of term debt (Million JPY)YoY (%)
Mar 31, 2026-6,748-2.32%
Mar 31, 2025-6,908-19.35%
Mar 31, 2024-8,565+38.19%
Mar 31, 2023-6,198-33.99%
Mar 31, 2022-9,390-19.83%
Mar 31, 2021-11,712+168.25%
Mar 31, 2020-4,366-59.87%
Mar 31, 2019-10,880+18.66%
Mar 31, 2018-9,169+53.17%
Mar 31, 2017-5,986-35.63%
Mar 31, 2016-9,300+79.16%
Mar 31, 2015-5,191

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat